AAN: Females at Higher Risk for Sports-Related Concussions

Share this content:
AAN: Females at Higher Risk for Sports-Related Concussions
AAN: Females at Higher Risk for Sports-Related Concussions

THURSDAY, March 2, 2017 (HealthDay News) -- Female athletes appear to be more likely than males to suffer concussions during their careers on the field, according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology, to be held from April 22 to 28 in Boston.

Cecilia Davis-Hayes, a medical student at Columbia University in New York City, and colleagues tracked 1,203 athletes from Columbia University from 2000 to 2014 -- 822 were male, and 381 were female. The athletes all played sports believed to pose a higher risk of concussions. For women, the sports included field hockey, soccer, basketball, softball, and lacrosse. For men, the sports initially included just football but then also included wrestling, basketball, and soccer.

The researchers found that 23 percent of the women and 17 percent of the men had at least one concussion during their college careers over the time of the study. Levels of most concussion symptoms were similar among the men and women, although forgetfulness was more common for men (44 percent reported it, compared to 31 percent of the women). Women were more likely to experience insomnia (42 percent, compared to 29 percent of men).

"It is unclear why women appear to be at higher risk for sports-related concussions than men," a coauthor said in a news release from the American Academy of Neurology. "The findings from this study highlight the need for more research on the gender differences in concussion."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »